It takes two to tango: Preserving daptomycin efficacy against daptomycin-resistant MRSA using daptomycin-phage co-therapy
ABSTRACT Daptomycin (DAP) is a cyclic lipopeptide antibiotic that targets the cell membrane and is commonly used for the treatment of multidrug-resistant Staphylococcus aureus infections, especially methicillin-resistant strains (MRSA). Emergence of DAP resistance during DAP therapy is increasingly...
Saved in:
| Main Authors: | Casey L. Madison, Anja S. J. Steinert, Corrin E. Luedeke, Neeka Hajjafar, Prakhar Srivastava, Andrew D. Berti, Arnold S. Bayer, Razieh Kebriaei |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American Society for Microbiology
2024-12-01
|
| Series: | Microbiology Spectrum |
| Subjects: | |
| Online Access: | https://journals.asm.org/doi/10.1128/spectrum.00679-24 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Real-time multimodal imaging of daptomycin action on the cell wall of adherent Staphylococcus aureus
by: Alexis Canette, et al.
Published: (2025-02-01) -
Daptomycin-Induced Acute Eosinophilic Pneumonia: Late Onset and Quick Recovery
by: Mohamad Rachid, et al.
Published: (2017-01-01) -
Metabolic engineering of Streptomyces roseosporus for increased production of clinically important antibiotic daptomycin
by: Xingwang Li, et al.
Published: (2024-11-01) -
Differences in Method-Specific Vancomycin MICs and Induced Daptomycin Resistance in an Infective Endocarditis Patient
by: David Benjamin Lash, et al.
Published: (2015-01-01) -
A prospective study to evaluate high dose daptomycin pharmacokinetics and pharmacodynamics in spp. infective endocarditis
by: Simona De Gregori, et al.
Published: (2025-01-01)